Sign up for a free trial and join thousands of other leading professionals. Click here to start!

Bladder Cancer News

Home | Index > Health > Cancer > Bladder Cancer

TAKE THIS POLL
Is Belgian Prime Minister Herman Van Rompuy the right person to lead the EU as its president? (Nov. 20, 2009) Yes. No. Don't know.

Sort by: relevance (24 hours) relevance date

The effect of age and gender on bladder cancer: a critical review of the literature 23 Nov 2009 07:43 GMT
... Division of Urology/Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. While patient ... decision-making for treating urothelial carcinoma of the bladder (UCB), there are no evidence-based recommendations to ...
Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: Diagnostic review bias in the randomized, prospective CEFUB trial 23 Nov 2009 07:43 GMT
... underwent standard 3-month cystoscopy. The primary outcome measure was the number of histologically proven bladder cancer recurrences. At a median 34-month followup 218 recurrences were detected in the intervention arm ...
UPDATE 1-Spectrum inks deal with Korea's Handok for cancer drug 23 Nov 2009 13:27 GMT
... ) will develop and commercialize Spectrum's experimental cancer drug in South Korea as part of ... tested for the treatment of non-muscle invasive bladder cancer. Spectrum will receive upfront payment, milestones ...
Spectrum inks deal with Korea's Handok for cancer drug 23 Nov 2009 14:34 GMT
... <002390.KS> will develop and commercialize Spectrum's experimental cancer drug in South Korea as part of ... tested for the treatment of non-muscle invasive bladder cancer. Spectrum will receive upfront payment, milestones ...
Spectrum Pharmaceuticals and Handok Pharmaceuticals Announce Collaboration Agreement for Apaziquone in South Korea 23 Nov 2009 12:30 GMT
... Apaziquone is an antineoplastic agent currently being investigated for the treatment of non-muscle invasive bladder cancer by intravesical instillation. Spectrum Pharmaceuticals has previously entered into a strategic collaboration with Allergan, ...

Spectrum Pharmaceuticals, Handok Pharmaceuticals sign collaboration agreement 23 Nov 2009 13:26 GMT
... Apaziquone is an antineoplastic agent currently being investigated for the treatment of non-muscle invasive bladder cancer by intravesical instillation. Spectrum Pharmaceuticals has previously entered into a strategic collaboration with Allergan, ...
The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion--the prognostic contribution of related molecular markers 23 Nov 2009 07:43 GMT
... Instituto Superior de Saúde do Alto Ave, Isave, Portugal. Bladder cancer is the second most common malignancy of the urogenital region. The majority of bladder ...
FDA has posted an Advisory Committee meeting with Photocure to discuss Hexvix NDA 23 Nov 2009 14:53 GMT
... significantly improved detection (p=0.001) of non-invasive papillary cancer using Hexvix cystoscopy compared to standard white ... light cystoscopy in patients with non-invasive papillary bladder cancer. The improved detection was followed by ...
Crown Equity Holdings, Inc.: CRWENews Highlights: GDP, SPPI 23 Nov 2009 14:55 GMT
... Apaziquone is an antineoplastic agent currently being investigated for the treatment of non-muscle invasive bladder cancer by intravesical instillation. Spectrum Pharmaceuticals is a commercial-stage biotechnology company with a primary focus ...
OLD AGE SOLUTIONS (Portal on Technology Solutions For Elderly) 23 Nov 2009 10:51 GMT
... also vulnerable to heinous diseases like Diabetes, Cancer, Urinary incontinence, heart obstructions, dementia and arthritis. ... body movements which put pressure on the bladder. It occurs in most women in all ...

Not satisfied with this news section? Make your own with the Newsletter Manager or try our other media monitoring services.

Seattle Genetics and Agensys, an Affiliate of Astellas, Expand Antibody-Drug Conjugate Collaboration 23 Nov 2009 14:31 GMT
... “Combining Agensys' proprietary antibodies, directed to novel cancer targets, with Seattle Genetics' industry-leading ADC technology ... those of the prostate, kidney, pancreas, ovary, bladder, lung, colon, breast and skin. ADC products ...
Urodynamix Technologies Ltd. Provides Update on US Reimbursement 23 Nov 2009 14:50 GMT
... CPT Code 51795, "Voiding pressure studies (VP); bladder voiding pressure, any technique," will be discontinued ... lower urinary tract symptoms, erectile dysfunction, prostate cancer, benign prostatic hyperplasia, and traumatic increases in ...
Sciele Pharma, a Shionogi Company, Presents Pivotal Study for PSD502 ' The First Potential Treatment for Premature Ejaculation ' At the Sexual Medicine Society of North America (SMSNA) 23 Nov 2009 02:14 GMT
... new research areas such as allergy and cancer. Contributing to the health of patients around ... clinical development for the treatment of overactive bladder, stress urinary incontinence, interstitial cystitis, gynaecological pain, ...
Sciele Pharma, a Shionogi Company, Presents Pivotal Study for PSD502 ? The First Potential Treatment for Premature Ejaculation ? At the Sexual Medicine Society of North America (SMSNA) 23 Nov 2009 03:10 GMT
... new research areas such as allergy and cancer. Contributing to the health of patients around ... clinical development for the treatment of overactive bladder, stress urinary incontinence, interstitial cystitis, gynaecological pain, ...
Exploring cancer research, the classic 'Sakura' and filial piety 22 Nov 2009 00:30 GMT
... Exploring cancer research, the classic 'Sakura' and filial piety ... critic Takashi Tachibana was operated on for bladder cancer. The experience made him curious about ...
Building Bladders Inside the Body 22 Nov 2009 04:32 GMT
... option that boosts the chances of survival for patients who lose an organ to cancer. Daniel Lehrman's battle with bladder cancer began nine years ago. He fought and won twice. Then it came back ...
Leominster officials say city water is safe to drink 22 Nov 2009 13:12 GMT
... trihalomethanes, which the Environmental Protection Agency has linked to an elevated risk for developing cancer, particularly bladder cancer. Dave Reckhow, a professor of environmental and civil engineering at the University of ...
Below the belt 22 Nov 2009 23:11 GMT
... a part in the development of prostate cancer, while the causal relationship between obesity and ... prostate�s awkward location - just under the bladder and surrounding the urethra. This means men ...
I am useless as a professor - Dalai Lama 22 Nov 2009 00:56 GMT
... told reporters at the launch of a cancer centre at Max hospital in Saket, south ... Gangaram Hospital for removing his "problematic" gall bladder which had agonised him for 15 years. ...
Smoking-Related Bladder Cancer on the Rise 17 Nov 2009 00:56 GMT
... Explain to interested patients that the risk of bladder cancer from smoking appears to be on the rise due to past reformulations of cigarettes. ...

THESE STORIES ARE NOT PUBLISHED BY IPD GROUP, INC. AND THESE LINKS WILL TAKE YOU TO OTHER WEBSITES. SOME OF THESE WEBSITES REQUIRE THEIR OWN REGISTRATION TO READ THEIR STORIES. PLEASE READ THE DISCLAIMER FOR MORE DETAILS. >>>

Bladder Cancer Risks Increase Over Time for Smokers 17 Nov 2009 02:33 GMT
... It is well known that cigarette smoking causes bladder cancer, but the influence of various parameters of smoking history, including trends in risk over ...
Smokers more vulnerable to bladder cancer 17 Nov 2009 11:35 GMT
... Washington, Nov 17 (IANS) Smokers face a five times higher risk of developing bladder cancer compared to non-smokers, according to a new study. Researchers found that among individuals who ...
Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-{kappa}B and upregulation of TRAIL Receptors 18 Nov 2009 06:14 GMT
... Departments of Urology, Cancer Biology, and Experimental Therapeutics, The University of ... intravesical therapy is a standard treatment for bladder cancer, eventual failure of response is a ...
Combinations of urine-based tumour markers in bladder cancer surveillance 17 Nov 2009 06:13 GMT
... markers including urinary cytology (Cytology or Cyt) increase the sensitivity in the detection of bladder cancer recurrence. Urinary cytology, NMP22, UroVysion (FISH) and ImmunoCyt (uCyt+) were determined in 221 patients ...
Multidisciplinary meeting on urological cancers aims to benefit cancer patients 19 Nov 2009 15:37 GMT
... meeting on urological cancers aims to benefit cancer patients Arnhem, November 2009 -- Experts agree ... Urological Cancers (EMUC) Embracing Excellence in Prostate, Bladder and Kidney Cancer - which is to ...